Discover Top 10 Rabies Vaccine Producers in India 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global demand for rabies vaccines continues to grow steadily, driven by increasing awareness of the disease and the importance of preventative measures. In India, a key player in the pharmaceutical industry, the production of rabies vaccines is a significant segment of the market. With a focus on quality and innovation, Indian companies have established themselves as leaders in this sector. According to recent reports, the market for rabies vaccines in India is expected to reach a value of over $100 million by 2026.

Top 10 Rabies Vaccine Producers in India 2026:

1. Bharat Biotech
Bharat Biotech is a pioneer in the field of vaccine production in India, with a strong focus on research and development. The company’s rabies vaccine, Rabipur, is one of the most widely used vaccines in the country, with a market share of over 30%.

2. Serum Institute of India
Serum Institute of India is renowned for its high-quality vaccines, including its rabies vaccine, Rabishield. The company’s production volume of rabies vaccines is estimated to be over 5 million doses annually, making it a top player in the market.

3. Indian Immunologicals Limited
Indian Immunologicals Limited has a long-standing history of producing vaccines, including its rabies vaccine, Abhayrab. The company’s exports of rabies vaccines to various countries contribute significantly to its market share.

4. Panacea Biotec
Panacea Biotec is a key player in the Indian pharmaceutical industry, with a diverse portfolio of vaccines, including its rabies vaccine, Rabivax. The company’s focus on innovation and quality has helped it establish a strong presence in the market.

5. Zydus Cadila
Zydus Cadila is a leading pharmaceutical company in India, known for its cutting-edge research and development capabilities. The company’s rabies vaccine, Lyssavac, is highly sought after for its efficacy and safety profile.

6. Bio-Med
Bio-Med is a trusted name in the Indian vaccine market, with a strong presence in the production of rabies vaccines. The company’s commitment to quality and affordability has made its vaccines accessible to a wide range of consumers.

7. Hester Biosciences
Hester Biosciences is a key player in the animal health segment, with a focus on vaccines for livestock and pets. The company’s rabies vaccine for animals is widely used by veterinarians and pet owners across the country.

8. Biological E Limited
Biological E Limited is a leading manufacturer of vaccines in India, with a strong presence in the rabies vaccine market. The company’s commitment to research and development has resulted in the production of highly effective vaccines for various diseases, including rabies.

9. Cadila Healthcare
Cadila Healthcare is a major player in the Indian pharmaceutical industry, with a diverse portfolio of products, including vaccines. The company’s rabies vaccine, Rabifast, is known for its high efficacy and safety profile.

10. Lupin Limited
Lupin Limited is a well-known name in the Indian pharmaceutical industry, with a focus on research and development. The company’s rabies vaccine, Rabicad, is a popular choice among healthcare providers for its effectiveness in preventing the disease.

Insights:

The market for rabies vaccines in India is expected to witness significant growth in the coming years, driven by increasing awareness of the disease and the importance of vaccination. With a focus on innovation and quality, Indian companies are well-positioned to meet the growing demand for vaccines both domestically and internationally. According to industry reports, the market for rabies vaccines in India is projected to grow at a CAGR of over 8% from 2021 to 2026, reaching a value of over $100 million by the end of the forecast period. This growth is expected to be fueled by factors such as government initiatives to control rabies, increasing pet ownership, and rising healthcare expenditure in the country. Indian vaccine producers are poised to capitalize on these opportunities and further strengthen their position in the global market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →